UniQuest logo

UniQuest

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series B

Vicebio logo
Vicebio

Biopharmaceutical

TCGX logo
venBio logo
UniQuest logo
Medicxi logo
Goldman Sachs Alternatives logo
Avoro Ventures logo

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

Series B
$100M
09/23/2024
Article